Abstract
Sir, The aim of this letter is to show our experience in the use of leflunomide (LFN) and express our opinion about the recommended dose [1, 2]. As far as we know, no data exist about a possible association between the loading dose and the presence of adverse events. Any new suggestion about the use of LFN should be appreciated, specially after the safety of this drug has been questioned.